tirzepatide surmount 2 Lilly released results for SURMOUNT-2, a trial of in people with T2D and obesity or overweight at 72 weeks: 🔘10 mg: -13.4% BW 🔘15 mg: -15.7% BW ⭐️Important: at this point Tirzepatide Matches Dulaglutide in Large

Increased fluid intake causes more urination

Here are some questions to start crucial conversations with your vendors: Questions to Ask Your PBM: Its crucial that your pharmacy benefit manager (PBM) partner is transparent with their GLP-1 procedures and provides executional tools for cost control

Predictive nuclear chromatin characteristics of melanoma and dysplastic nevi

Smooth offramp: Patients who eventually transition to maintenance (or pregnancy planning) report fewer rebound cravings than with more aggressive agents, likely because weight loss is steady, not steep

All your gut is doing is adapting and reacting to a level of receptor stimulation it has never encountered before

mg-to-units conversion at 5, 10, and 20 mg/mL, legitimacy checks, and how to read your vial